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ABSTRACT 
Purpose: Skeletal muscle wasting is well documented in chronic heart failure (CHF). This paper 
provides a more detailed understanding of the morphology behind this muscle wasting and the 
relationship between muscle morphology, strength and exercise capacity in CHF. We investigated 
the impact of CHF on leg lean mass, detailed muscle-tendon architecture of the individual triceps 
surae muscles (soleus, SOL; medial gastrocnemius, MG and lateral gastrocnemius, LG) and how 
these parameters relate to exercise capacity and strength. Methods: 11 CHF patients and 15 age-
matched controls were recruited. Leg lean mass was assessed by dual energy X-ray absorptiometry 
(DXA) and the architecture of skeletal muscle and tendon properties by ultrasound. Plantarflexor 
strength was assessed by dynamometery. Results: Patients with CHF exhibited ~25% lower 
combined triceps surae volume and physiological cross-sectional area (PCSA) compared to control 
subjects (p < 0.05), driven in large part by reductions in the SOL. Only the SOL volume and the 
SOL and MG PCSA were statistically different between groups after normalizing to lean body mass 
and body surface area, respectively. Total lower leg lean mass did not differ between CHF and 
control subjects, further highlighting the SOL specificity of muscle wasting in CHF. Moreover, the 
volume of the SOL and plantarflexor strength correlated strongly with peak oxygen uptake 
( peakoV 2
.
) in patients with CHF.  Conclusions: These findings suggest that the SOL may be a 
sentinel skeletal muscle in CHF and provide a rationale for including plantarflexor muscle training 
in CHF care. 
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INTRODUCTION 
Paragraph number 1 
Impaired exercise capacity is a hallmark symptom of chronic heart failure (CHF) (8, 9). The 
important contribution of peripheral, as against cardiac, factors in the functional limitation which 
characterizes CHF has long been recognized and is reinforced by the finding that cardiac function is 
poorly correlated with exercise capacity (9). Moreover, it appears that dysfunctional skeletal 
muscles have a direct influence on the reduced exercise capacity evident in patients with CHF (8), 
and may contribute to a progressive deterioration in clinical status. These findings resulted in the 
‘muscle hypothesis’ of CHF (8), which proposes that skeletal muscle dysfunction is a key factor 
responsible for reduced exercise capacity in this group. 
 
Paragraph number 2 
Consistent with the ‘muscle hypothesis’, muscle wasting is common in patients with CHF (8, 
24), especially in advanced disease. It has been found that limb muscle mass is correlated with 
reduced exercise capacity (peak oxygen consumption; peakoV 2
.
) (7). Indeed, a recent analysis of 
200 CHF patients (12) revealed that reduced muscle mass is independently associated with lower 
absolute peakoV 2
.
 (ml min-1) when age, sex, ejection fraction and co-morbidities are accounted for, 
and that muscle mass is directly linked to disease progression. 
 
Paragraph number 3 
Skeletal muscle wasting is therefore highly relevant to the progression and treatment of CHF.  
However, whilst an overall reduction in skeletal muscle mass in CHF is evident, a more detailed 
understanding of the morphology behind muscle wasting and the relationship between muscle 
morphology, muscle functional capacity (strength) and exercise capacity in CHF remains 
unexplored. For example, it is not known whether loss of mass occurs evenly across lower limb 
muscles, or if certain muscles exhibit proportionately more/less muscle wasting. It is conceivable 
that predominantly slow-twitch muscles may be more markedly affected, given the reported 
increase in the proportion of type-II fibers (8), the reduced blood flow and vascular transport 
capacity in CHF (31) and reports that type-I fiber atrophy is related to severity of the disease (10). It 
is also possible that muscle wasting is more prominent in the distal leg muscles, given their greater 
functional role in generating the mechanical work and power for walking and for the maintenance 
of posture (25). The “architectural” changes that underlie the loss of muscle mass are also poorly 
understood. Loss of muscle mass may occur through decreased fiber length, with physiological 
cross-sectional area (PCSA) of the muscle remaining unaffected, or through loss of PCSA with 
fiber length remaining unaffected, or a combination of these. The distinction is important, given that 
whole-muscle architecture is a strong predictor of skeletal muscle mechanical capacity (e.g. 
strength) (21) and may also impact muscle energetics (35). Finally, the mechanical function of a 
muscle is also dependent on in-series tendon properties. Tendons function by storing and releasing 
elastic energy during locomotion, thereby influencing the contractile behavior of muscle, including 
work and power production and efficiency (20). Tendon mechanics are known to be closely 
associated with muscle wasting in ageing and chronic unloading (32, 38). To the best of our 
knowledge, a detailed structural analysis combining muscle volume, fiber length and pennation 
angle along with tendon properties has not previously been undertaken in human CHF, nor have 
they been analysed in relation to muscle strength or exercise capacity in this group. 
 
Paragraph number 4 
The aims of the present study were therefore: 1) To assess whether muscle wasting in CHF is 
constant across different muscles of the lower limb, in particular across synergist muscles known to 
differ in fiber composition and function; 2) To assess the detailed architecture of synergist skeletal 
muscle and tendon properties in patients with CHF, compared to healthy age-matched control 
participants (with similar adiposity and exercise activity); 3) To assess how skeletal muscle 
architecture, muscle strength and exercise capacity are related among CHF patients and control 
participants. To address these questions we analyzed leg lean mass and performed a detailed 
architectural assessment of the triceps surae (calf muscles) and Achilles tendon, along with 
functional strength measurements of this muscle group. The triceps surae [soleus (SOL), medial 
gastrocnemius (MG) and lateral gastrocnemius (LG)] were chosen because they offer a highly 
relevant comparison between synergist muscles known to possess different fiber types 
(predominantly slow twitch in SOL vs. mixed fibers in gastrocnemius) (13). Furthermore, the 
triceps surae muscles are functionally important, representing the main source of power during 
walking (25) and have been shown to be a major locus of gait impairment in ageing (11, 34). 
 
MATERIALS AND METHODS 
Paragraph number 5 
Subjects. We recruited 11 subjects with CHF (7 men, 4 women; NYHA II-IV; EF = 30 ± 10 %; 
age: 61.8 ± 10.0 yr; height: 1.68 ± 0.10 m; weight: 72.8 ± 18.0 kg).  Criteria for exclusion included 
severe renal (creatinine>250mmol/L or eGFR< 30ml/min/1.73m2) or hepatic (bilirubin>50mmol/L) 
dysfunction, unexplained anaemia (haemoglobin<100g/L) or thrombocytopaenia (platelets 
<100x109/L), unstable angina or exercise-induced ischaemia at low exercise levels, severe aortic 
stenosis, severe mitral or aortic regurgitation, or hypertrophic cardiomyopathy. All CHF subjects 
were medically stable at the time of testing. The CHF group was attending supervised exercise 
training 2-3 times per week for ~ 1 hour per session (treadmill walking, cycle ergometry and 
resistance training) as part of their multidisciplinary care.  
 
The control group consisted of 15 healthy subjects recruited from the local community (9 men, 6 
women; age: 60.7 ± 6.2 yr; height: 1.72 ± 0.07 m; weight: 69.9 ± 8.6 kg). Eleven of these control 
subjects were recruited because they matched the CHF group for age, sex and adiposity and had 
similar levels of exercise to those of the CHF patients, and were used in comparative statistics. The 
additional 4 controls were recruited specifically to validate the ultrasound measurement of muscle 
volume (a total of 6 participants were used for ultrasound validation). All subjects provided written 
informed consent prior to participating in the study. All procedures were approved by the Human 
Research Ethics Committee at The University of Western Australia (approval ID: RA/4/1/2533) and 
Royal Perth Hospital (approval ID: 2011/019). 
 
Paragraph number 6 
Body composition measurements. Overall body composition was determined using dual 
energy X-ray absorptiometry (DXA) (Luna Prodigy, encore 2004, GE Medical Systems, Madison, 
WI, USA) on each subject including a measurement of total fat-free mass, total fat mass and bone 
mineral density. Lean mass for the lower limbs was computed separately by selecting a region of 
interest from the greater trochanter to the pubic symphysis and included the leg and foot. 
 
Paragraph number 7 
Triceps surae volume calculation. Due to the presence of internal cardioverter defibrillators 
in 10 of the 11 CHF subjects, rendering MRI unsuitable, muscle volume was computed using a 
three-dimensional ultrasound technique (3DUS) based on a combination of B-mode ultrasound 
imaging and 3D motion data (2). Subjects kneeled with their right leg in a custom-designed plastic 
water bath equipped with an adjustable metal footplate designed to secure the subject’s foot and to 
set the ankle joint angle to 0° (i.e. foot perpendicular to the tibia), with the knee in 10° flexion (near 
maximal extension). The water bath was maintained within a temperature range of 24-25°C to 
ensure that temperature-dependent variations in the speed of sound were minimized. 
 
Paragraph number 8 
Ultrasound images (Telemed, Echoblaster128, Lithuania; 7.5 MHz linear array probe) and 3D 
marker trajectories of a probe-mounted marker cluster that defined the probe position in space (5-
camera Vicon MX system, 250 Hz; Oxford Metrics, UK) were used to calculate muscle volume. 
The ultrasound and motion capture systems were synchronized using a 3V square pulse generated at 
the beginning of the images collection by the ultrasound device. The subjects’ lower leg was 
scanned longitudinally from the popliteal cave to the calcaneus. Three sweeps were performed to 
scan the whole triceps surae, starting at the lateral side and ending medially so that each sweep 
overlapped by a minimum of 20 mm. A customized MATLAB script (The MathWorks Inc., USA) 
was then used to combine ultrasound images and 3D position data and to convert them to Stradwin 
format (Medical Imaging Research Group, Cambridge University Engineering Department, UK) 
(2). Manual segmentation of the muscles was performed in Stradwin software by a single 
investigator (FAP) on approximately 30 slices covering the length of the muscle group (inter slice 
gap ~ 15 mm). Muscle volumes for the three muscles under investigation (SOL, MG and LG) were 
computed. The segmentation procedure and analysis of muscle volumes was conducted in a blinded 
manner to avoid operator bias. To account for the possible variability during data collection and 
manual segmentation, the collection procedure described above was repeated three times for each 
subject and an average volume for the SOL, MG and LG computed.  
 
Paragraph number 9 
We conducted comparisons between our ultrasound volume measurements and those obtained 
from axial plane MRI scans of the lower leg in a subsample (n = 6) of control subjects who were 
able to undergo this form of imaging. MRI scans were collected using a Magnetom Espree 1.5T 
scanner (Siemens, Erlangen, Germany) with the subjects’ leg position matched to that of the 3DUS 
experiment (see Text, Supplemental Digital Content 1, which describes the full details of the MRI 
procedures). The accuracy of the CSA of the Achilles tendon was also assessed by comparing 
ultrasound and MRI-derived images.   
 
 
Paragraph number 10 
Fascicle length, pennation angle and muscle physiological cross-sectional area (PCSA). 
The ultrasound probe described above was first placed over the middle of the selected muscle belly 
(SOL, MG, LG) following the guidelines of Rubenson et al. (36), with its longitudinal axis aligned 
with the orientation of the fascicle. Fascicle length and pennation angle at neutral ankle (0º) and 10º 
knee flexion joint angles (approximating the angle where passive fascicle forces and net joint torque 
approach zero, Ref. 36, 1) were calculated in ImageJ, as per Rubenson et al. (36). For a better 
characterization of the muscle anatomy, fascicle lengths of the SOL and MG muscles were also 
calculated in the proximal, medial and distal locations of the muscle, with approximately 4 cm 
spacing between each location. 
 
Paragraph number 11 
The functional range of mid-belly fascicle length in the SOL and MG were also assessed using a 
dynamometer (Biodex, M3, Shirley, NY, USA) with continuous recording of passive muscle 
fascicle lengths and joint angle across the ankle range of motion (the most dorsiflexed and most 
plantarflexed position tolerated by the participant using a passive isokinetic (5°/sec) protocol).  To 
assess the length range of the SOL the knee was positioned at 120° of flexion, minimizing the 
passive force contribution of the MG and LG (1). The length range of the MG was assessed with the 
knee extended. Ankle joint angles were obtained using a 3-camera OptiTrack motion capture 
system (Natural Point, Corvallis, OR; 100 Hz). The assessment of regional muscle lengths and 
functional length range was performed only on the MG and SOL in order to shorten the testing time 
and avoid discomfort of prolonged experimentation in the CHF group. For each muscle, 
physiological cross-sectional area (PCSA) was calculated as: 
 PCSA = (muscle volume * cos(θ)) / fascicle length (1) 
Fascicle length and pennation angles used for the PCSA calculation were obtained at the mid-belly 
position of the muscle from images collected in the 3DUS water bath experiment. PCSA was 
expressed in cm-2 and subsequently normalized to body surface area (BSA) calculated as per 
Moesteller (27). 
 
Paragraph number 12 
Tendon length and cross-sectional area. A scaled subject specific musculoskeletal model in 
OpenSim 2.0.2 (1) was used to estimate the muscle-tendon unit lengths for each subject at 0° of 
plantarflexion and 10° knee flexion. Tendon length, defined as the free tendon plus aponeurosis 
(series elastic element), was subsequently calculated as the difference between the estimated 
muscle-tendon unit length of each of the SOL, MG and LG obtained by the scaled OpenSim model 
and the estimated muscle length from ultrasound of the respective muscles (fascicle length *cos(θ)) 
at an ankle angle of 0° (Fig.1). An average of the three tendon lengths was obtained with this 
procedure (see Text, Supplemental Digital Content 2, which describes the triceps surae tendon 
length estimates). 
 
Paragraph number 13 
Using the same setup and settings described for the determination of 3D muscle volume, 
ultrasound images of Achilles tendon cross sectional area (CSA) were taken at the level of the 
medial malleolus to standardize the measurements across participants. To obtain tendon CSA, 
images were manually digitized in ImageJ.  
 
Paragraph number 14 
Strength. Strength measurements were assessed by means of a robotic dynamometer (M3, 
Biodex, Shirley, NY, USA). Subjects sat with their right foot strapped to a custom built foot plate 
designed to align the centre of rotation of the ankle with that of the Biodex and to minimize heel 
movement during the contraction.  Subjects performed three maximum voluntary contractions with 
the knee extended (10° flexion) and the ankle dorsiflexed to 10°, approximating the angle at which 
the maximum torque is produced at the ankle joint (1, 36). A minimum of two minutes was 
observed between repetitions. Peak torque was calculated as the difference between the maximum 
torque during contraction and the torque measured at rest arising primarily from the weight of the 
rig and foot and small passive muscle forces (36). Analog data were collected using a CED data 
acquisition system running Spike2 V7 software (Micro1401-3; Cambridge Electronic Design, 
Cambridge, UK; 2000 Hz) and processed by means of a custom written program in MATLAB (The 
Mathworks, Natick, MA). For each subject the trial with the highest peak torque was reported and 
used for comparisons. 
 
Paragraph number 15 
Exercise capacity. Peak oxygen uptake ( peakoV 2
.
) was assessed using a purpose-designed 
incremental walking protocol on a motorized treadmill, starting at a speed 20% slower than each 
individual’s preferred speed with stepwise increases in speed and grade every 3 min until the 
participant reached volitional exhaustion. Indirect calorimetry was conducted using a Vmax Encore 
gas analysis system (Sensormedics, Yorba Linda, California), which enabled the measurement of 
expired gas concentrations and volumes. Absolute peakoV 2
.
 was expressed in ml min-1 and 
normalized to body mass (ml kg-1 min-1). All tests were performed by an exercise physiologist 
(AJM) experienced with undertaking cardiopulmonary exercise testing in patients with heart failure 
(22).  
 
Paragraph number 16 
Statistics. Differences in muscle volume (absolute and lean body mass-normalized) and PCSA 
(absolute and BSA-normalized) were analyzed using a two-way between groups ANOVA with 
group (CHF/control) and muscle synergist (SOL/MG/LG) as fixed factors. Differences in muscle 
fascicle length were analyzed using a two-way between groups ANOVA with group (CHF/control) 
and muscle synergist (SOL/MG/LG) as fixed factors for the mid-belly location. A two-way between 
groups ANOVA with group (CHF/control) and muscle synergist (SOL/MG) as fixed factors was 
performed for the proximal and distal locations. If a significant interaction effect between group and 
muscle was observed (p < 0.05) a one-way ANOVA with group as a fixed factor was performed for 
each muscle. A one-way ANOVA was used to determine differences in the fascicle length range 
and pennation angle, leg lean mass, strength and tendon properties between groups. ANOVAs were 
performed in SPSS using a Bonferroni post hoc analysis (IBM, Statistic 21, USA). 
 
Paragraph number 17 
Linear regression was used to determine correlations between peakoV 2
.
 and a) lean leg mass, b) 
muscle volume, c) muscle PCSA (total triceps surae as well as single muscles) and d) strength, and 
between the muscle PCSA and tendon cross-section. A correlation analysis was also performed 
between 3DUS- and MRI-derived measurements of muscle volume and the agreement between the 
two techniques was assessed using the limits of agreement method (6). Correlation coefficients (r) 
and significance level (p < 0.05) were determined in SPSS. Values presented are mean ± SD unless 
otherwise stated. 
 
RESULTS 
Paragraph number 18 
Subject characteristics. No significant differences in age, height or mass or other 
anthropometric characteristics were observed between control and CHF groups; leg length was 0.38 
± 0.04 m in the CHF group and 0.40 ± 0.02 m in the control group (p = 0.14); adiposity (fat body 
mass) was 21.3 ± 11.3 kg in CHF group and 17.8 ± 7.2 kg in the control group (p=0.38); peakoV 2
.
 
was 15.5 ± 3.0 ml kg-1 min-1 in CHF and 35.6 ± 8.3 ml kg-1 min-1 in control (p < 0.0001). It should 
be noted that one CHF patient and two control participants did not undergo strength testing due to 
discomfort and in one CHF subject image degradation prevented an accurate SOL volume.   
 
Paragraph number 19 
DXA lean mass and triceps surae muscle volume and PCSA. Total body lean mass (49.0 ± 
10.6 kg, CHF; 49.2 ± 8.3 kg, control; p = 0.95) and leg lean mass (7.6 ± 1.9 kg, CHF; 8.3 ± 1.5kg, 
control; p = 0.4) as assessed by DXA did not significantly differ between groups. The two-way 
ANOVA determined a main effect of both group and muscle on absolute volume (p = 0.015 and p < 
0.0001, respectively) and volume normalized to lean body mass (p = 0.007 and p < 0.0001, 
respectively). Post hoc analysis found that volumes collapsed over groups were statistically 
different between all muscles (p < 0.01).  The combined muscle volume of the triceps surae was, on 
average, 27.2% higher in the control group compared to the CHF group (632 ± 169 ml vs 497 ± 155 
ml; Fig. 2a). A significant interaction effect between group and muscle was found in the lean mass-
normalized volume (p = 0.03). Post hoc analysis revealed a significant difference in the normalized 
SOL muscle volume between the CHF and control group (20.5% smaller) but not in the MG or LG 
(Fig. 2b). A trend towards an interaction effect was also observed between group and muscle in the 
absolute muscle volume (p = 0.08) and was largely due to the small difference in LG volume 
between the CHF and control group (8.7% smaller) compared to the SOL (27.5% smaller) and the 
MG (20.9% smaller) 
 
Paragraph number 20 
From the volume renderings of the triceps surae muscle group (Fig. 3a), an average difference 
of 20 ± 46 ml was observed between 3DUS and MRI techniques for the combined triceps surae 
muscles. This difference amounted to 2.5 ± 6.3% difference between measurements of the total 
triceps surae volume between the two techniques. The average difference in volume for each 
individual muscle was 4.2%. The overall correlation coefficient between 3D Ultrasound and MRI 
was 0.989 (Fig. 3b) and the 95% confidence interval ranged between +47 and -33 ml (Fig. 3c). 
 
Paragraph number 21 
No main effect of group on fascicle length or interaction effect between group and muscle were 
observed in any ANOVAs. However, a main effect of muscle on fascicle length was observed for 
the comparison in the distal muscle location (p = 0.04; Table 1). No significant differences were 
found in fascicle lengths or joint angles across the functional ankle range of motion between the 
CHF and control subjects. A main effect of both group and muscle were found for absolute PCSA 
(p < 0.0001 for both). A main effect of both group and muscle were also found for BSA-normalized 
PCSA (p < 0.0001 for both). Post hoc analysis found that PCSA collapsed across groups were 
statistically different between all muscles (p < 0.01). The PCSA of triceps surae in the control group 
was, on average, 23.7% higher than in the CHF group (Fig. 2c). Interaction effects between muscle 
and group were found in the absolute PCSA (p = 0.042) and in the BSA-normalized PCSA (p = 
0.024). Post hoc analysis found significant differences between the SOL and MG absolute PCSA 
from the CHF and control groups but not for the LG. The average absolute PCSA of the SOL and 
MG were 22.2% and 25.3% smaller in the CHF group than in the control group, respectively (Fig. 
2c). Similar results were observed for the BSA-normalized PCSA whereby only the SOL and MG 
were significantly different between groups (Fig. 2d).    
 
Paragraph number 22 
A significant correlation between total lean lower limb mass and absolute peakoV 2
.
 (ml min-1; r 
= 0.82, p = 0.004) and total triceps surae volume and absolute peakoV 2
.
 (ml min-1; r = 0.93, p < 
0.0001) was observed in the CHF group (Fig. 4?). When analyzed on an individual muscle level, 
only the SOL body-mass normalized volume was found to correlate with the body mass normalized 
peakoV 2
.
 (ml kg
-1 min-1) in the CHF group (r = 0.72, p = 0.018; Fig.4?).  The control group 
exhibited weaker correlations between lean leg mass and absolute peakoV 2
.
 and triceps surae 
volume and absolute peakoV 2
.
 (r = 0.63, p = 0.06 and r = 0.58, p = 0.08, respectively).  Unlike the 
CHF group, body mass normalized data were not correlated in the control group. Muscle PCSA was 
independent of peakoV 2
.
 in all muscles in both the CHF and control groups. 
 
Paragraph number 23 
Tendon architectural parameters. The cross-sectional area of the Achilles tendon was 
significantly smaller in CHF patients compared to the control group (59.2 ± 16.1 mm-2 vs. 73.4 ± 
20.0 mm-2 respectively, p = 0.046). However the estimate of tendon length was not different 
between the CHF (27.4 ± 2.7 cm) and control (28.6 ± 2.3 cm) groups (p = 0.2).  A trend towards a 
positive correlation between tendon CSA and the triceps surae PCSA existed for CHF (r = 0.65, p = 
0.06) but not for the control group (r = 0.35, p = 0.3). 
 
Paragraph number 24 
Strength measurements. Body-mass normalized peak torque (N m kg-1) was 13.3% greater in 
the control group vs. the CHF group, although this difference was not statistically different (p = 0.3; 
Fig. 5a.).  Peak torque normalized by the triceps surae PCSA (N m cm-2) was 3.6% smaller (non-
significant) in the control group vs. the CHF group (p = 0.8; Fig. 5b).  A strong correlation between 
body-mass normalized peak torque and peakoV 2
.
 was found in the CHF group (r = 0.75; p < 0.01) 
but there was no such relationship in the control group (r = 0.25; p = 0.5; Fig. 5c). 
 
 
DISCUSSION 
Paragraph number 25 
There is growing evidence that skeletal muscle is adversely affected in patients with CHF and that it 
contributes to the reduced exercise capacity characteristic of this condition. Skeletal muscle 
wasting, in particular, has been shown to be strongly correlated with exercise capacity and disease 
progression in CHF (12), yet little data exists on the specifics of wasting between muscles, or the 
involvement of whole muscle-tendon morphology in muscle wasting. The present study 
investigated total leg lean mass and detailed muscle-tendon architecture and strength of the triceps 
surae muscles (calf muscles), an important functional muscle group for maintaining posture and for 
locomotion (25). We assessed architectural and strength differences between CHF and control 
subjects, as well as relationships with exercise capacity. Whilst there were no detectable differences 
in lower limb lean mass as measured by DXA, a clear reduction in the size of the SOL and to a 
lesser extent the MG, and a reduction in Achilles tendon CSA, were observed in the CHF compared 
with control subjects. However, these differences did not translate to statistically significant 
differences in strength. Furthermore, SOL muscle volume and plantarflexor strength were found to 
strongly correlate with exercise capacity in the CHF group, but not in the control group. These 
findings offer the possibility that the distal lower limb muscles, and the SOL in particular, may be 
key skeletal muscles determining exercise capacity and function in CHF patients. 
 
Paragraph number 26 
Is muscle wasting in CHF muscle-specific? Whilst several studies have identified generalized 
muscle wasting in CHF (12, 24), little is known about the specificity of muscle loss. Interestingly, 
our 3DUS data revealed that muscle wasting was not uniform across the three muscles of the triceps 
surae. Although the overall reductions in triceps surae muscle volume and PCSA observed in this 
study are comparable to one previous MRI-based report assessing triceps surae volume in CHF 
(24), our novel observation is that the reductions in these parameters are seen only in the SOL, and 
(with respect to volume) to a somewhat lesser extent in the MG. The lack of atrophy in the LG 
might be related to a difference in muscle mechanical function (16), or possibly a consequence of 
its relatively small size and limited contribution to posture (16). The more pronounced reduction in 
muscle volume in the SOL compared to the MG in CHF patients (Fig. 2; in particular when 
normalized to total leg lean mass) could suggest that muscle wasting is sensitive to muscle aerobic 
capacity and fiber composition, given the known differences in type I vs. type II fiber distribution 
between these muscles (13). Greater CHF-induced atrophy in type I compared to type II fibers has 
been reported for the human vastus lateralis (40), although the opposite has been found in other 
work reporting fiber type-specific fiber atrophy in CHF (23). In a rat model of CHF, type I fiber 
atrophy has been correlated to the severity of the disease (10) and, recently, significant atrophy in 
the rat soleus (predominantly type I fibers) but not the plantaris has been observed (29). 
Alternatively, the SOL volume may be more affected in CHF due to reduced blood flow (31), or 
possibly because the SOL has been shown to provide the majority of mechanical work among the 
lower limb muscles during walking (25) and thus the effect of CHF may be augmented in this 
functionally important muscle. 
 
Paragraph number 27 
Whereas ultrasound-based measurements of triceps surae volume revealed marked reduction in 
muscle size (~ 30%), DXA measurements of total lower limb lean mass were, surprisingly, only 
slightly lower (non-significant) in CHF patients compared to the control group. The ~ 0.7 kg (7.8%) 
reduction in total lower limb lean mass is similar to that reported by Toth et al. (39), who also found 
non-significant differences in lean mass between CHF and an age-matched control group. When 
taken together, the high-fidelity 3DUS of the calf muscles and whole-limb DXA recording suggest 
that the SOL and MG may be particularly prominent, and possibly early sites of muscle loss in 
CHF.  Fülster et al. (12) found that 20% of CHF patients (NYHA class II-III) exhibited muscle 
wasting compared with a healthy reference group. Using their criteria, only 30% of participants in 
the current study would be diagnosed with generalized leg muscle wasting, yet these patients 
exhibited muscle wasting in the SOL and MG. It seems likely that muscle-specific changes in the 
triceps-surae may have gone undetected in previous analyses of overall leg lean mass using DXA. 
This may relate to the relatively small size of the triceps surae muscles (~500g) compared to the 
total leg lean mass (~ 7.5 kg) and the lower sensitivity of DXA (~300g sensitivity in detecting 
muscle mass; Ref. 19) compared to 3DUS (~35 ml sensitivity; Fig. 3c).  
 
Paragraph number 28 
We are unaware of previous studies describing muscle-specific atrophy in CHF. Our data offer 
the intriguing possibility that calf muscle volume, and the SOL in particular, may be a sentinel 
muscle for early muscle wasting in this disease. Greater distal muscle atrophy has previously been 
documented in ageing (27) and in other conditions of unloading, such as bed rest (18, 32) and space 
flight (32). However, in these studies a more prominent reduction in total lower limb lean mass was 
observed compared to the present study. We propose that a distal-to-proximal gradation in muscle 
loss may occur due to the prominent role of the distal muscles in body support and propulsion (25). 
Muscle wasting may be amplified, especially in the major plantarflexor muscles compared to the 
other leg muscles, including the LG (16), that have a lower contribution to these functions in 
activities of daily living, and in particular walking. The SOL and MG play a key role in supporting 
the trunk during single-leg stance and pre-swing (33) and the SOL is fundamental for the horizontal 
acceleration in the late stance phase, which is necessary to provide propulsion to the trunk (33). 
Because of their importance to gait mechanics, it can be argued that a ~25% reduction in 
normalized muscle volume and PCSA in the SOL will have a negative impact on function. It is 
reasonable to hypothesize, therefore, that alterations in gait and movement mechanics and fatigue in 
CHF will result as a consequence of the reduction in size of the triceps surae, and especially the 
SOL. 
 
Paragraph number 29 
The relationship between muscle-tendon architecture and wasting in chronic heart 
failure.  Muscle architecture analyses revealed that the loss of muscle volume is primarily a result 
of a loss of muscle PCSA, with muscle length and pennation angles remaining relatively 
unchanged. Age-related muscle wasting, on the other hand, has been reported to result, in part, from 
a reduction in muscle length (38), although recent work suggests that the active muscle lengths in 
the MG may be unaffected by age (3). Our findings therefore suggest a pattern of CHF muscle 
atrophy that is distinct from that associated with aging per se. Given that volume (17) and PCSA 
(21) influence a muscle’s mechanical work and force capacity, respectively, our findings suggest a 
biomechanical basis for impaired function of the calf muscles in CHF patients. It was somewhat 
surprising, therefore, that a more pronounced reduction in strength was not observed between the 
CHF and control groups in the present study. Interestingly, a lack of statistically significant 
differences in ankle strength is consistent with previous measurements of voluntary plantarflexor 
torque in CHF (14), and possibly reflect variability in voluntary torque measurements arising from 
factors such as neural drive, co-contraction, muscle moment arm lengths (4) and/or fiber operating 
lengths (36). Despite the lack of statistical differences in absolute strength, it is also worth noting 
that the differences between groups are minimized when normalized for PCSA. 
 
Paragraph number 30 
Similar to other studies addressing triceps surae muscle loss (18), the current study also 
showed that the Achilles tendon undergoes a concurrent reduction in cross-sectional area in CHF 
patients. Tendon remodeling occurs in response to the mechanical loading stimulus (37) and it 
follows, therefore, that the reduced triceps surae muscle size in the CHF patients may be associated 
with reduced habitual in vivo muscle forces.  
 
 
Paragraph number 31 
The relationship between muscle architecture, strength and exercise capacity in chronic 
heart failure. Previous studies have reported significant correlations between estimates of skeletal 
muscle mass and functional capacity in CHF (12, 24). Indeed, several studies have reported 
correlations between total lower limb lean mass or the size of specific muscle groups and peakoV 2
.
 
(typically expressed as absolute peakoV 2
.
 ml min-1). Our findings suggest, for the first time, that a 
principal reason for such leg muscle mass correlations may relate specifically to the relationship 
between SOL muscle volume and peakoV 2
.
. We observed correlations between SOL volume and 
peakoV 2
.
 (absolute and body mass normalized) in CHF, but no such correlation between peakoV 2
.
 
and the MG or LG. Whilst similar correlations between the combined calf muscle volume and 
peakoV 2
.
 have been observed (24), our finding reinforces the suggestion that the SOL muscle may 
be of particular importance as a determinant of functional capacity in CHF patients. This may relate 
to the SOL being an important determinant of aerobic potential due to its high oxidative capacity 
(13), as well as its key functional role in gait (25). Indeed the size of the gastrocnemius, a muscle 
known to have a lower oxidative capacity (13), did not correlate with peakoV 2
.
 in our study. It 
should be noted that similar to the present study, Harrington et al. (15) reported correlations 
between both quadriceps and thigh cross sectional area and absolute peakoV 2
.
 in CHF. However, 
the strong correlations observed in this study were likely due, in part, to the high covariance 
between body mass and muscle size and absolute peakoV 2
.
. When thigh and quadriceps cross 
sectional area were correlated to body-mass normalized peakoV 2
.
, relatively weak correlations were 
observed compared to that of the SOL in the present study. Furthermore, it should be noted that 
Harrington et al. (15) assessed quadriceps anatomical cross sectional area from a single axial plane 
image, and thus may not represent the average physiological cross sectional area of the muscle 
(typically requiring volume and fiber length and pennation angle measurements). Interestingly, our 
results also suggest that it may be reduced muscle volume per se, more so than PCSA that is linked 
with reduced peakoV 2
.
 in CHF.  
 
Paragraph number 32 
The link between the SOL function and peakoV 2
.
 in CHF is also supported by the strong 
correlation between plantarflexor torque, for which the SOL is the major contributor, and peakoV 2
.
 
in these patients. We are unaware of previous studies correlating plantarflexor strength and 
peakoV 2
.
 in CHF, although the strength of quadriceps has been previously shown to correlate with 
peakoV 2
.
 in CHF (26). That both the SOL muscle size and plantarflexor strength are correlated to 
peakoV 2
.
 only in the CHF group supports the notion that peripheral determinants of peakoV 2
.
 may 
be present to a greater extent in CHF patients compared to healthy adults (8).  
 
Paragraph number 33 
Limitations. The present study compared CHF patients to control subjects matched for age and 
with similar adiposity. We cannot rule out the possibility that reduced activity levels in the CHF 
patients contributed, at least in part, to the reduced muscle and tendon size and the relationship 
between muscle volume, strength and exercise capacity observed in this study. There are several 
factors, however, that lead us to conclude that any influence of activity levels on our findings is 
likely to have been minimal. Firstly, all CHF patients were engaged in an exercise rehabilitation 
program and were undertaking supervised exercise 2-3 times weekly, similar to the activity of the 
control participants. Secondly, our finding that the reduction in muscle volume and PCSA as well as 
the relationship between muscle volume and peakoV 2
.
 is highly muscle specific would not be 
expected as a result of disuse alone, which should logically be expressed generically. For example, 
while disuse studies have found muscle loss in distal leg muscles (18), they also reported loss in the 
total lower limb lean mass (18). In contrast the present study only found a clear loss of muscle in 
the SOL, with no differences in total lower limb lean mass from DXA. Thirdly, the SOL has been 
reported to have a smaller reduction in size (or no reduction) compared to the MG and LG as a 
result of ageing/disuse (3, 30), whereas in the present study on CHF the SOL presents the largest 
reduction in size. 
 
Paragraph number 34 
Conclusion. The SOL is a key muscle involved in postural control and locomotion. It is 
classically considered to possess a higher proportion of type I muscle fibers than other muscles of 
the triceps surae and lower limb. Our findings indicate that SOL wasting is particularly marked in 
CHF, even when compared to other lower limb muscles in these individuals. Furthermore, the SOL 
volume correlated strongly with exercise capacity, whereas other individual leg muscle volumes did 
not, and is largely responsible for the correlation between plantarflexor strength and peakoV 2
.
. For 
these reasons we propose that the SOL is a key muscle reflecting loss of function and exercise 
capacity in CHF, and may thus be a sentinel skeletal muscle in CHF patients. Finally, our results 
offer an evidence-base for including calf muscle-specific exercise training to help restore functional 
capacity in CHF. 
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Figure captions 
 
 
Fig. 1. Schematic illustration of the procedure for obtaining triceps surae tendon length. (a) Subject 
marker set used for motion capture of skeletal elements, (b) Subject-specific scaled 
OpenSim model depicting the MG and SOL muscle tendon units, (c) Ultrasound 
measurement of muscle fascicle length and pennation angle, (d) Prediction of tendon length 
(see Text, Supplemental Digital Content 2, which describes the tendon length estimate). 
 
Fig. 2. Muscle volume and physiological cross-sectional area (PCSA) values for the total triceps 
surae and individual plantarflexors. (a) Absolute volume, (b) lean body mass-normalized 
volume, (c) Absolute PCSA, and (d) BSA normalized PCSA. Data are means ±  S.D. The 
(#) indicates a main effect (p < 0.05; ANOVA) of group (CHF/Control; volume and PCSA 
collapsed over individual triceps surae muscles). The (*) indicates a statistical difference 
(one-way ANOVA) between group (CHF/Control).  A one-way ANOVA was performed 
only when an interaction effect between group and muscle were present. TS = triceps surae, 
SOL = soleus, MG = medial gastrocnemius, LG = lateral gastrocnemius, CHF = chronic 
heart failure). 
 
Fig.3. 3D-ultrasound and MRI-derived muscle volume. (a) Example of 3D volume rendering of the 
triceps surae created with 3D ultrasound (3DUS) and with MRI from the same individual.  
SOL = soleus, MG = medial gastrocnemius, LG = lateral gastrocnemius. (b) The correlation 
between volume calculation using 3DUS imaging and MRI (equation y = 0.998x + 9.365, r 
= 0.988, p< 0.001).  The solid line represents the line of best fit and the dotted lines 
represent the 95% prediction interval. (c) Bland-Altman plot of the difference between 
3DUS and MRI vs. the average of the MRI and 3DUS values. The horizontal lines on the 
plot represent the mean difference between MRI and 3DUS and the upper and lower 95% 
limits of agreement.  
 
Fig.4. Relationship between peakoV 2
.
 and leg muscle size. Relationship between absolute 
peakoV 2
.
 (ml min-1) and (a) leg lean mass (kg) and (b) triceps surae volume (ml). 
Relationship between body mass normalized peakoV 2
.
 and individual muscle volume in (c) 
the combined triceps surae, (d) soleus, (e) medial gastrocnemius, and (f) lateral 
gastrocnemius. Chronic heart failure subjects are displayed in grey triangles (▲) and control 
subjects in open circles ().   
 
Fig.5. Peak plantarflexor torque values and their relationship with peakoV 2
.
. Peak plantarflexor 
torque normalized to (a) body mass and (b) triceps surae PCSA. Data are means ± S.D. (c) 
Relationship between body mass-normalized peakoV 2
.
 and body mass-normalized peak 
plantarflexor torque. Note one additional subject was added to the CHF group that was 
tested in a parallel study. Chronic heart failure subjects are displayed in grey triangles (▲), 
and control subjects in open circles (). 
 
